Haase V: Difference between revisions
From Bioblast
No edit summary |
Marte Verena (talk | contribs) No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
|firstname=Volker | |firstname=Volker | ||
|title=MD | |title=MD | ||
|institution=Nephrology - School of Medicine | |||
Vanderbilt University | |||
|address=1161 21st Avenue South | |||
C-3119 A MCN | |||
|area code=37232-2372 | |||
|city=Nashville | |city=Nashville | ||
|state=Tennessee (TN) | |state=Tennessee (TN) | ||
| Line 11: | Line 18: | ||
|topics=Hypoxia, hypoxia-inducible factors, EPO | |topics=Hypoxia, hypoxia-inducible factors, EPO | ||
}} | }} | ||
Latest revision as of 14:46, 10 April 2013
| Name | Haase Volker, MD |
|---|---|
| Institution | Nephrology - School of Medicine
Vanderbilt University |
| Address | 1161 21st Avenue South
C-3119 A MCN, 37232-2372 |
| City | Nashville |
| State/Province | Tennessee (TN) |
| Country | USA |
| volker.haase@vanderbilt.edu | |
| Weblink | |
| O2k-Network Lab | US TN Nashville Wasserman DH |
Labels:
Topics: Hypoxia, hypoxia-inducible factors, EPO
Publications
Add references to your publications
